Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-04 1:03 pm Sale | 13G | Evofem Biosciences, Inc. EVFM | Woodford Investment Management Ltd | 0 0% | -3,913,274![]() (Position Closed) | View |
2020-02-04 1:01 pm Sale | 13G | Nightstar Therapeutics plc NITE | Woodford Investment Management Ltd | 0 0% | -1,921,315![]() (Position Closed) | View |
2019-11-08 3:01 pm Sale | 13G | Theravance Biopharma, Inc. TBPH | Woodford Investment Management Ltd | 429,770 0.76% | -11,886,759![]() (-96.51%) | View |
2019-11-08 2:58 pm Sale | 13G | Evofem Biosciences, Inc. EVFM | Woodford Investment Management Ltd | 3,913,274 8.3% | -8,582,948![]() (-68.68%) | View |
2019-10-09 12:28 pm Sale | 13G | Autolus Therapeutics plc AUTL | Woodford Investment Management Ltd | 2,095,127 4.7% | -8,518,751![]() (-80.26%) | View |
2019-09-09 4:33 pm Sale | 13G | Prothena Corporation plc PRTA | Woodford Investment Management Ltd | 0 0% | -8,773,790![]() (Position Closed) | View |
2019-09-09 4:23 pm Sale | 13G | NuCana plc NCNA | Woodford Investment Management Ltd | 1,538,000 4.8% | -1,692,999![]() (-52.40%) | View |
2019-08-08 3:13 pm Sale | 13G | Evofem Biosciences, Inc. EVFM | Woodford Investment Management Ltd | 12,496,222 26.8% | -497,770![]() (-3.83%) | View |
2019-08-08 3:10 pm Sale | 13G | Autolus Therapeutics plc AUTL | Woodford Investment Management Ltd | 10,613,878 23.6% | -1,311,541![]() (-11.00%) | View |
2019-07-09 2:59 pm Sale | 13G | Prothena Corporation plc PRTA | Woodford Investment Management Ltd | 8,773,790 22% | -3,150,824![]() (-26.42%) | View |
2019-05-10 11:52 am Purchase | 13G | Evofem Biosciences, Inc. EVFM | Woodford Investment Management Ltd | 12,993,992 35.3% | 975,264![]() (+8.11%) | View |
2019-04-15 11:47 am Purchase | 13G | NuCana plc NCNA | Woodford Investment Management Ltd | 3,230,999 10% | 1,365,999![]() (+73.24%) | View |
2019-02-14 3:48 pm Purchase | 13G | NuCana plc NCNA | Woodford Investment Management Ltd | 1,865,000 5.8% | 1,865,000![]() (New Position) | View |
2019-02-14 3:45 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Woodford Investment Management Ltd | 1,921,315 5.8% | 1,921,315![]() (New Position) | View |
2019-02-14 3:37 pm Purchase | 13G | Prothena Corporation plc PRTA | Woodford Investment Management Ltd | 11,924,614 29.9% | 396,000![]() (+3.43%) | View |
2019-02-14 3:34 pm Purchase | 13G | Theravance Biopharma, Inc. TBPH | Woodford Investment Management Ltd | 12,316,529 22.2% | 1,569,421![]() (+14.60%) | View |
2019-02-14 3:18 pm Unchanged | 13G | Northwest Biotherapeutics, Inc. NWBO | Woodford Investment Management Ltd | 24,815,028 4.8% | 0 (Unchanged) | View |
2019-01-10 12:11 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Woodford Investment Management Ltd | 11,925,419 29.7% | 2,261,417![]() (+23.40%) | View |
2018-12-10 2:40 pm Purchase | 13G | Evofem Biosciences, Inc. EVFM | Woodford Investment Management Ltd | 12,018,728 42.5% | 1,999,999![]() (+19.96%) | View |